Physician profile
Algis P Sidrys
NPI 1104873090
$542.41
in general payments reported to CMS, 2019-2025
18 companies · $189 in 2025
The $189 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179 · 2020: $42.27 · 2023: $80.76 · 2024: $51.03 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $320.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $124.95 | 2025 | Libtayo |
| Exelixis INC. | $55.75 | 2019-2020 | |
| Progenics Pharmaceuticals, INC. | $51.03 | 2024 | |
| Blue Earth Diagnostics | $42.03 | 2019 | |
| Aveo Pharmaceuticals, INC. | $39.88 | 2023 | Fotivda |
| E.R. Squibb & Sons, L.L.C. | $30.47 | 2019-2023 | Opdivo |
| Novartis Pharmaceuticals Corporation | $27.55 | 2025 | |
| Seagen INC. | $23.19 | 2023 | Tukysa |
| Biocompatibles, INC. | $19.54 | 2019 | |
| Tesaro, INC. | $19.44 | 2019 | |
| Teleflex LLC | $18.59 | 2025 | Barrigel |
| Glaxosmithkline, LLC. | $17.86 | 2025 | Blenrep |
| Elekta, INC. | $15.78 | 2020 | |
| Emd Serono, INC. | $15.28 | 2019 | |
| Kite Pharma, INC. | $14.89 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $13.41 | 2019 | |
| Pfizer INC. | $12.77 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Algis Sidrys listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.